ETF Managers Group, LLC Zynerba Pharmaceuticals, Inc. Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Zynerba Pharmaceuticals, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 723,151 shares of ZYNE stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares

723,151

Previous 1,510,872 52.14%

Holding current value

Previous $800,000 61.25%

% of portfolio

0.01%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$0.4 - $0.67 $315,088 - $527,773	-787,721 Reduced 52.14%	723,151 $310,000
Q4 2022 Mar 23, 2023	SELL	$0.5 - $0.72 $374,049 - $538,630	-748,098 Reduced 33.12%	1,510,872 $800,000
Q3 2022 Nov 14, 2022	SELL	$0.87 - $1.36 $163,940 - $256,274	-188,437 Reduced 7.7%	2,258,970 $1.65 Million
Q2 2022 Aug 15, 2022	SELL	$0.86 - $2.06 $1.04 Million - $2.5 Million	-1,214,935 Reduced 33.17%	2,447,407 $2.82 Million
Q1 2022 May 13, 2022	SELL	$1.83 - $3.02 $1.69 Million - $2.79 Million	-923,399 Reduced 20.14%	3,662,342 $7.87 Million
Q4 2021 Feb 14, 2022	BUY	$2.88 - $4.3 $351,264 - $524,458	121,967 Added 2.73%	4,585,741 $13.3 Million
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $429,682 - $617,957	-115,506 Reduced 2.52%	4,463,774 $18.7 Million
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $9.93 Million - $15.5 Million	2,591,494 Added 130.37%	4,579,280 $24.8 Million
Q1 2021 May 17, 2021	BUY	$3.33 - $8.76 $577,615 - $1.52 Million	173,458 Added 9.56%	1,987,786 $9.24 Million
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.64 $3.02 Million - $4.28 Million	923,303 Added 103.62%	1,814,328 $5.99 Million
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $1.13 Million - $1.51 Million	-350,571 Reduced 28.24%	891,025 $2.95 Million
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $110,785 - $218,893	33,470 Added 2.77%	1,241,596 $4.18 Million
Q1 2020 May 14, 2020	SELL	$2.9 - $6.16 $2.4 Million - $5.1 Million	-828,404 Reduced 40.68%	1,208,126 $4.63 Million
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $3.61 Million - $5.51 Million	-642,927 Reduced 23.99%	2,036,530 $12.3 Million
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $3.34 Million - $6.82 Million	441,614 Added 19.73%	2,679,457 $20.3 Million
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $12.1 Million - $34.7 Million	2,237,843 New	2,237,843 $30.3 Million

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Zynerba Pharmaceuticals, Inc. Transaction History